Navigation Links
AbbVie to Present at Cowen and Company 33rd Annual Health Care Conference
Date:2/20/2013

NORTH CHICAGO, Ill., Feb. 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the Cowen and Company 33rd Annual Health Care Conference on Wednesday, March 6, 2013.  Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at 7:40 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations Web site at www.abbvieinvestor.com.  An archived edition of the presentation will be available later that day.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.


'/>"/>
SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AbbVie Declares Dividend and Announces Share Repurchase Program
2. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
3. PDL BioPharma to Present at Two Upcoming Investor Conferences
4. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend; Announces Live Webcasts Of Presentations At Two Upcoming Conferences
5. Patheon to Present at Informex USA
6. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
7. Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare Conference
8. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
9. Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference
10. Selexis SA to Present at Cell Line Development and Engineering 2013
11. 10 Fastest Ways to Land a Medical Sales Job Presented by Nationally Renowned Career Coach, Peggy McKee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... of medical marijuana products targeting the needs of consumers who are incorporating medical ... takes place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... the healthcare and technology sector at their fourth annual Conference where founders, investors, ... inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health and ...
Breaking Biology Technology:
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):